MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Multiple system atrophy with predominant striato-nigral degeneration (MSA-P) and TDP-43 pathology: an unusual pathologic variant of MSA

    L. Nwabuobi, D. Tomishon, N. Shneider, S. Fahn, J. Vonsattel, E. Cortes (New York, NY, USA)

    Objective: To report a patient with MSA with concomitant occurrence of TDP-43-labeled and a-synuclein labeled inclusions in oligodendrocytes. Background: The pathologic hallmark in multiple system atrophy…
  • 2019 International Congress

    The Progressive Supranuclear Palsy Functional Disability Scale: Sensitivity to change

    I. Piot, K. Schweyer, G. Respondek, M. Grimm, M. Stamelou, P. Sckopke, T. Schenk, C. Goetz, G. Stebbins, G. Höglinger (Munich, Germany)

    Objective: To determine the sensitivity to change within 12 months as well as completion time of the Progressive Supranuclear Palsy Functional Disability Scale (PSPFDS). Background:…
  • 2019 International Congress

    Early stage Parkinson’s disease patients with GBA mutation have more severe motor symptoms and difficult to differentiate in routine clinical practice

    S. Abe, K. Komatsu, H. Satoi, H. Saiki, Y. Oka (Osaka, Japan)

    Objective: The objective of this study is to compare clinical features of early stage of Parkinson’s disease (PD) between with and without positive glucocerebrosidase (GBA)…
  • 2019 International Congress

    THOR 201: A Proof-of-Concept Study Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of L-dopa delivered by Impel’s Precision Olfactory Delivery (PODTM) to Parkinson’s Disease Patients in an OFF Episode (in the presence of Dopa Decarboxylase Inhibitor)

    S. Shrewsbury, J. Campbell, M. Swardstrom, A. Lehn, K. Satterly, J. Hoekman (Seattle, WA, USA)

    Objective: Impel NeuroPharma has developed the patient-friendly, self or caregiver actuatedPrecision Olfactory Delivery (IMPEL PODTM) device to achieve consistent upper nasal cavity drug delivery, rapid…
  • 2019 International Congress

    Medical and Device-Guided Therapies and Deep Brain Stimulation in Parkinson’s disease: Experience of a Tertiary Centre from Turkey

    Y. Sucullu Karadag, D. Divanlıoglu, E. Kocabicak, N. Subutay Oztekin, D. Belen (Ankara, Turkey)

    Objective: This study is aimed to investigate the clinical and therapeutic data of PD patients who have been evaluated at a dedicated-weekly Movement Disorders Clinic. Details…
  • 2019 International Congress

    MRI cortical layer study in patients with Parkinson’s disease in Uzbekistan

    A. Umarov, D. Tolibov (Tashkent, Uzbekistan)

    Objective: We aimed to establish, using MRI, the presence of differences in the thickness of the cortical layers in patients with early and developed stages…
  • 2019 International Congress

    Alpha-synuclein seeding activity in blood samples from synucleinopathy patients

    T. Yamasaki, E. Song (Lexington, KY, USA)

    Objective: Utilize a cell-based assay to determine whether a-syn seeding activity can be amplified and  detected from blood components from patients with Parkinson’s disease (PD)…
  • 2019 International Congress

    Relationship of cognitive processing speed with postural stability in non-demented Parkinson’s disease patients

    J. Andreo Jover, A. Arroyo Ferrer, P. López Serrano, J. Periañez, M. Rios-Lago, G. Lubrini, JP. Romero Muñoz (Madrid, Spain)

    Objective: To measure in PD patients with normal cognitive screening the clinical and instrumental measures of postural stability (PS) and analyze their relationship with cognitive…
  • 2019 International Congress

    The differential role of subthalamic and nigral neurons in gait control in Parkinson´s disease patients

    A. Gulberti, M. Horn, J. Wagner, M. Schaper, J A. Koeppen, C. Buhmann, A. Sharott, M. Westphal, A K. Engel, C. Gerloff, W. Hamel, CKE. Moll, M. Pötter-Nerger (Hamburg, Germany)

    Objective: The aim of the study was to identify and characterize subthalamic (STN) and nigral (SNr) neurons showing gait-related activity changes. 12 Parkinson’s disease (PD)…
  • 2019 International Congress

    First Experience with MR-guided Focused Ultrasound in the Treatment of X-linked Dystonia-Parkinsonism (XDP)

    WC. Chang, T. Taira, RDG. Jamora, PY. Chiu, W. Lin (Changhwa, Taiwan)

    Objective: Feasibility treatment in X-linked dystonia Parkinsonism with MR guided focused ultrasound. Background: XDP is a sex-linked disease initially presented with distal dystonia and rapidly…
  • « Previous Page
  • 1
  • …
  • 153
  • 154
  • 155
  • 156
  • 157
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley